Waters Corporation Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Waters Corporation (WAT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 133.00 thousand shares for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-04.
Discontinued › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2018-05-04
- Waters Corporation share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2018-03-31 was 133.00K shares, a 35.75% decline year-over-year.
- Waters Corporation share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2017-12-31 was 172.00K shares, a 27.73% decline year-over-year.
- Waters Corporation share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2017-09-30 was 10.00K shares.
- Waters Corporation share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2017-07-01 was 0.00 shares.
- Waters Corporation share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2017 was 389.00K shares, a 20.06% increase from fiscal 2016.
- Waters Corporation share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2016 was 324.00K shares, a 51.86% decline from fiscal 2015.
- Waters Corporation share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2015 was 673.00K shares, a 18.28% increase from fiscal 2014.
- Waters Corporation share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2014 was 569.00K shares, a 32.94% increase from fiscal 2013.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2018-03-31 | 133.00K shares 10-Q · filed 2018-05-04 | 305.00K shares derived: sum of 2 quarters · filed 2018-05-04 | 315.00K shares derived: sum of 3 quarters · filed 2018-05-04 | 315.00K shares derived: sum of 4 quarters · filed 2018-05-04 |
| 2017-12-31 | 172.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | 182.00K shares derived: sum of 2 quarters · filed 2018-02-27 | 182.00K shares derived: sum of 3 quarters · filed 2018-02-27 | 389.00K shares 10-K · filed 2018-02-27 |
| 2017-09-30 | 10.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | 10.00K shares derived: sum of 2 quarters · filed 2017-11-03 | 217.00K shares 10-Q · filed 2017-11-03 | 455.00K shares derived: sum of 4 quarters · filed 2018-02-27 |
| 2017-07-01 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | 207.00K shares 10-Q · filed 2017-08-04 | 445.00K shares derived: sum of 3 quarters · filed 2018-02-27 | 445.00K shares derived: sum of 4 quarters · filed 2018-02-27 |
| 2017-04-01 | 207.00K shares 10-Q · filed 2017-05-05 | 445.00K shares derived: sum of 2 quarters · filed 2018-02-27 | 445.00K shares derived: sum of 3 quarters · filed 2018-02-27 | 445.00K shares derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-12-31 | 238.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | 238.00K shares derived: sum of 2 quarters · filed 2018-02-27 | 238.00K shares derived: sum of 3 quarters · filed 2018-02-27 | 324.00K shares 10-K · filed 2018-02-27 |
| 2016-10-01 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | 0.00 shares derived: sum of 2 quarters · filed 2017-11-03 | 86.00K shares 10-Q · filed 2017-11-03 | 644.00K shares derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-07-02 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | 86.00K shares 10-Q · filed 2017-08-04 | 644.00K shares derived: sum of 3 quarters · filed 2018-02-27 | 722.00K shares derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-04-02 | 86.00K shares 10-Q · filed 2017-05-05 | 644.00K shares derived: sum of 2 quarters · filed 2018-02-27 | 722.00K shares derived: sum of 3 quarters · filed 2018-02-27 | 727.00K shares derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | 558.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | 636.00K shares derived: sum of 2 quarters · filed 2018-02-27 | 641.00K shares derived: sum of 3 quarters · filed 2018-02-27 | 673.00K shares 10-K · filed 2018-02-27 |
| 2015-10-03 | 78.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | 83.00K shares derived: sum of 2 quarters · filed 2016-11-07 | 115.00K shares 10-Q · filed 2016-11-07 | |
| 2015-07-04 | 5.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-04 | 37.00K shares 10-Q · filed 2016-11-04 | ||
| 2015-04-04 | 32.00K shares 10-Q · filed 2016-05-06 | |||
| 2014-12-31 | 569.00K shares 10-K · filed 2017-02-24 | |||
| 2013-12-31 | 428.00K shares 10-K · filed 2016-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ILLUMINA, INC. (ILMN) | United States | $41.357B | 32.37 |
| AGILENT TECHNOLOGIES, INC. (A) | United States | $48.720B | 27.14 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |